1973年上海医药工业研究院发现磷酸喹哌(抗矽—14)对实验性矽肺具有防治效果。1974年上海劳动卫生职业病防治研究所首先开始临床试用。嗣后组成了协作组,全国先后有21个省市、70多个单位参加了临床验证。1978年在总结910例矽肺临床疗效的基础上进行了鉴定。确认该药对矽肺具有较好的效果。为进一步研究磷酸喹哌长期用药后的疗 1973 Shanghai Institute of Pharmaceutical Industry found that Quipiper phosphate (anti-silicon-14) on the experimental silicosis control effect. Shanghai Institute of Occupational Health and Disease Prevention in 1974 first started clinical trials. Subsequently formed a collaborative group, the country has 21 provinces and cities, more than 70 units participated in the clinical validation. In 1978, the clinical efficacy of 910 cases of silicosis was summarized based on the identification. Confirm the drug has a good effect on silicosis. For further study of long-term use of quinpid phosphate treatment